FindTrial
Sign In

Identification of Genetic Network unveils the pathologic mechanism of UTUC:A multi-omics and longitudinal cohort study

Study on the intratumor structure and pathogenesis of upper tract urothelial carcinoma based on transcriptional level

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086174
Enrollment
Unknown
Registered
2024-06-26
Start date
2023-11-15
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper urinary tract urothelial carcinoma

Interventions

UTUC group:None
Non-UTUC group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 150 Years

Inclusion criteria

Inclusion criteria: Trial group: Upper urothelial carcinoma was pathologically diagnosed without chemotherapy or any biological therapy; The tumor stage is not limited; Age =18 years old; Signed written informed consent; Long-term follow-up is possible. Control group: Healthy subjects without urothelial carcinoma.

Exclusion criteria

Exclusion criteria: Trial group: non-primary metastatic carcinoma of upper urothelium; Multiple primary cancers; Pregnant or lactating women with muscular invasive bladder cancer and other malignancies. Control group: had other malignancies.

Design outcomes

Primary

MeasureTime frame
Biomarker;—

Countries

China

Contacts

Public ContactHuang Jin

West China Hospital, Sichuan University

13086620225@163.com+86 156 8096 0102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026